Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Return on Assets %

Rigel Pharmaceuticals Return on Assets % Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Return on Assets % from 2010 to 2020.
  • Rigel Pharmaceuticals Return on Assets % for the quarter ending June 06, 2020 was -30.90 a 37.62% decrease of -11.63 year over year
  • Rigel Pharmaceuticals Return on Assets % for the last 12 months ending June 06, 2020 was -10.94 a -101.48% increase of 11.10 year over year
  • Rigel Pharmaceuticals Annual Return on Assets % for 2019 was -30.13 a -16.79% increase of 5.06 from 2018
  • Rigel Pharmaceuticals Annual Return on Assets % for 2018 was -35.18 a -43.40% increase of 15.27 from 2017
  • Rigel Pharmaceuticals Annual Return on Assets % for 2017 was -50.46 a 24.49% decrease of -12.36 from 2016
Other Margins & Efficiency Metrics:
  • Rigel Pharmaceuticals EBITDA Margin for the quarter ending December 12, 2018 was $7m a 801.93% increase of 57m year over year
  • Rigel Pharmaceuticals Return on Capital % for the quarter ending September 09, 2018 was -53.67 a -55.75% increase of 29.92 year over year
  • Rigel Pharmaceuticals Return on Equity % for the quarter ending September 09, 2018 was -83.74 a -57.61% increase of 48.24 year over year
View Chart On Koyfin

Quarterly RIGL Return on Assets % Data

06/2020-30.90
03/202036.14
12/2019-28.55
09/2019-19.28
06/2019-32.44
03/2019-29.46
12/20184.83
09/2018-46.09
06/2018-54.39
03/2018-56.75

Annual RIGL Return on Assets % Data

2019-30.13
2018-35.18
2017-50.46
2016-38.10
2015-22.62
2014-30.00
2013-20.47
2012-21.90
2011-24.33
201013.48